Guardant Health GH Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.08B+10.0% | $982.02M+8.8% | $902.57M+8.9% | $828.85M+7.1% | $774M+4.7% | ||
| $379.2M+8.7% | $349.01M+6.7% | $327.11M+6.2% | $308.01M+2.9% | $299.23M+3.3% | ||
| $701.01M+10.7% | $633.01M+10.0% | $575.46M+10.5% | $520.84M+9.7% | $474.77M+5.7% | ||
| 64.9%+0.4pp | 64.5%+0.7pp | 63.8%+0.9pp | 62.8%+1.5pp | 61.3%+0.6pp | ||
| $366.71M+0.7% | $364.19M+1.3% | $359.47M+0.7% | $356.82M+1.2% | $352.47M+1.4% | ||
| $559.48M+13.1% | $494.66M+8.5% | $456.04M+6.9% | $426.55M+9.7% | $388.83M+6.5% | ||
| $222.38M+5.2% | $211.41M+4.5% | $202.36M+2.1% | $198.22M+5.2% | $188.42M+4.6% | ||
| —— | $0— | $0— | $0— | $0— | ||
| $1.53B+7.6% | $1.42B+5.5% | $1.34B+4.3% | $1.29B+4.9% | $1.23B+3.9% | ||
| -$447.56M-2.4% | -$437.25M+1.2% | -$442.41M+4.0% | -$460.75M-1.3% | -$454.95M-2.6% | ||
| -41.4%+3.1pp | -44.5%+4.5pp | -49%+6.6pp | -55.6%+3.2pp | -58.8%+1.2pp | ||
| $4.45M+14.3% | $3.9M+15.9% | $3.36M+9.7% | $3.07M+12.4% | $2.73M+5.7% | ||
| $36.13M+6.0% | $34.1M-4.5% | $35.72M-14.1% | $41.58M-13.3% | $47.94M-10.7% | ||
| -$18.5M-76.3% | -$10.49M— | —— | —— | —— | ||
| —— | —— | —— | —— | $13.67M— | ||
| -$434.37M-4.0% | -$417.54M-5.0% | -$397.61M+3.7% | -$412.74M+0.6% | -$415.38M+4.5% | ||
| -$1.18M+6.5% | -$1.26M-207% | $1.18M+9.9% | $1.07M-8.1% | $1.17M-9.0% | ||
| -$433.19M-4.1% | -$416.28M-4.4% | -$398.79M+3.6% | -$413.82M+0.7% | -$416.55M+4.5% | ||
| -40.1%+2.3pp | -42.4%+1.8pp | -44.2%+5.7pp | -49.9%+3.9pp | -53.8%+5.2pp | ||
| -$3.39-2.4% | -$3.31-3.1% | -$3.21+4.2% | -$3.35+1.2% | -$3.39+4.8% | ||
| -$3.39-2.4% | -$3.31-3.1% | -$3.21+4.2% | -$3.35+1.2% | -$3.39+4.8% | ||
| 505.6M+1.5% | 498.2M+0.5% | 495.5M+0.4% | 493.8M+0.3% | 492.1M+0.4% | ||
| 505.6M+1.5% | 498.2M+0.5% | 495.5M+0.4% | 493.8M+0.3% | 492.1M+0.4% | ||
| -$18.5M-76.3% | -$10.49M— | —— | —— | —— | ||
| -$408.62M-2.8% | -$397.51M+1.2% | -$402.27M+4.1% | -$419.42M-1.5% | -$413.04M-2.9% | ||
| -37.8%+2.7pp | -40.5%+4.1pp | -44.6%+6.0pp | -50.6%+2.8pp | -53.4%+0.9pp | ||
| -$447.56M-2.4% | -$437.25M+1.2% | -$442.41M+4.0% | -$460.75M-1.3% | -$454.95M-2.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Guardant Health's revenue?
- Guardant Health (GH) generated $1.1B in revenue over the trailing twelve months, up 39.6% year over year.
- Is Guardant Health profitable?
- Guardant Health is not currently profitable: it reported a net loss of $433.2M over the trailing twelve months, a -40.1% net margin.
- What are Guardant Health's profit margins?
- Gross margin is 64.9% and operating margin is -41.4%, with a -40.1% net margin.
- What is Guardant Health's earnings per share?
- Guardant Health's diluted EPS over the trailing twelve months is $-3.39.
- Where does Guardant Health's income statement data come from?
- Every line is extracted from Guardant Health's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
